Tech Company Financing Transactions

AgeX Therapeutics Funding Round

AgeX Therapeutics closed a $4.5 million funding round on 3/25/2019. Investors included private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed. 17 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Mailing Address
1010 Atlantic Ave. 102
Alameda, CA 94501
Email Address
AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), is a biotechnology company applying technology relating to cellular immortality and regenerative biology to aging and age-related diseases.
AgeX Therapeutics LinkedIn Company Profile
Social Media
AgeX Therapeutics Company Twitter Account
Company News
AgeX Therapeutics News
AgeX Therapeutics on Facebook
AgeX Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael West
  Michael West LinkedIn Profile  Michael West Twitter Account  Michael West News  Michael West on Facebook
Chief Financial Officer
Russell Skibsted
  Russell Skibsted LinkedIn Profile  Russell Skibsted Twitter Account  Russell Skibsted News  Russell Skibsted on Facebook
Chief Information Officer
Ivan Labat
  Ivan Labat LinkedIn Profile  Ivan Labat Twitter Account  Ivan Labat News  Ivan Labat on Facebook
Chief Operating Officer
Nafees Malik
  Nafees Malik LinkedIn Profile  Nafees Malik Twitter Account  Nafees Malik News  Nafees Malik on Facebook
VP - Engineering
Aubrey de Grey
  Aubrey de Grey LinkedIn Profile  Aubrey de Grey Twitter Account  Aubrey de Grey News  Aubrey de Grey on Facebook
VP - General Counsel
Judith Segall
  Judith Segall LinkedIn Profile  Judith Segall Twitter Account  Judith Segall News  Judith Segall on Facebook
VP - R & D
Dana Larocca
  Dana Larocca LinkedIn Profile  Dana Larocca Twitter Account  Dana Larocca News  Dana Larocca on Facebook
VP - R & D
Hal Sternberg
  Hal Sternberg LinkedIn Profile  Hal Sternberg Twitter Account  Hal Sternberg News  Hal Sternberg on Facebook



Browse more venture capital transactions:

Prev: 3/25/2019: Saleswhale venture capital transaction
Next: 3/25/2019: Avidbots venture capital transaction


Share this article


About Database of VC Transactions

Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary